Effect of postprandial blood glucose level by the continuity intake of salmon milt peptides in placebo-controlled double blind cross over clinical trial - Effect of salmon milt peptides on postprandial blood glucose level

Hokkaido Information University0 个研究点目标入组 12 人开始时间: 2015年2月11日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Subjects who are under medication for diabetes and dyslipidemia. (2) HbA1c>=6.6% (3) FPG>=126mg/dl (4) Subjects with insulin resistance (HOMA-IR>=2.5) (5) Subjects with serious disease and infection (6) Subjects with clinical history of gastrointestinal surgery. (7) Subjects with unusually high and/or low blood pressure, or with abnormal hematological data. (8) Subjects with serious anemia. (9) Subjects with frequent complaints of post-menopausal symptoms. (10)Subjects with a history of allergy to medicine and food, especially salmon and gelatin. (11) Subjects routinely on supplementation which would affect glucose metabolism. (12) Subjects routinely on supplementation which would affect lipid metabolism. (13) Heavy smokers and alcohol addicts, or subjects with irregular lifestyle. (14) Subjects who donate 400ml whole blood within 12 weeks or who donate plasma or platelets within 4 weeks prior to supplementation. (15) Subjects who are pregnant or under lactation, or ones who would be expected to be pregnant during the study. (16) Subjects who participate in other clinical trials within the last one month prior to the current clinical trial. (17) Subjects who are not eligible due to physician's judgment.

发起方